Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease

World Journal of Gastroenterology

Volumn 14, Issue 18, 2008, Pages 2888-2893

  Huang, Xiao Dong ^a   Fan, Yan ^a   Zhang, Hen ^a   Wang, Ping ^a   Yuan, Jing Ping ^a   Li, Ming Jie ^a   Zhan, Xi Yan ^a  

^a CENTRAL HOSPITAL OF WUHAN   (China)

Author keywords

Leptin; Non alcoholic fatty liver disease; Soluble leptin receptor

Indexed keywords

C PEPTIDE; INSULIN; LEPTIN; LEPTIN RECEPTOR; LIPOPROTEIN;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; BLOOD SAMPLING; BODY MASS; CHOLELITHIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LIVER BIOPSY; MALE; NONALCOHOLIC FATTY LIVER; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN SECRETION; RADIOIMMUNOASSAY; RATING SCALE; STEATOSIS;

EID: 48049105312     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.2888     Document Type: Article

References (29)

1. Stenvinkel P, Lonnqvist F, Schalling M. Molecular studies of leptin: implications for renal disease. Nephrol Dial Transplant 1999; 14: 1103-1112
2. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Wool EA, Monroe CA, Tepper RI. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995; 83: 1263-1271
3. Lammert A, Kiess W, Bottner A, Glasow A, Kratzsch J. Soluble leptin receptor represents the main leptin binding activity in human blood. Biochem Biophys Res Commun 2001; 283: 982-988
4. Lahlou N, Clement K, Carel JC, Vaisse C, Lotton C, Le Bihan Y, Basdevant A, Lebouc Y, Froguel P, Roger M, Guy-Grand B. Soluble leptin receptor in serum of subjects with complete resistance to leptin: relation to fat mass. Diabetes 2000; 49: 1347-1352
5. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231
6. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997; 126: 137-145
7. Day CP, James OF. Hepatic steatosis: innocent bystander or guilty party? Hepatology 1998; 27: 1463-1466
8. Chitturi S, Farrell G, Frost L, Kriketos A, Lin R, Fung C, Liddle C, Samarasinghe D, George J. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Hepatology 2002; 36: 403-409
9. Uygun A, Kadayifci A, Yesilova Z, Erdil A, Yaman H, Saka M, Deveci MS, Bagci S, Gulsen M, Karaeren N, Dagalp K. Serum leptin levels in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2000; 95: 3584-3589
10. Giannini E, Botta F, Cataldi A, Tenconi GL, Ceppa P, Barreca T, Testa R. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C. Hepatogastroenterology 1999; 46: 2422-2425
11. Nakao K, Nakata K, Ohtsubo N, Maeda M, Moriuchi T, Ichikawa T, Hamasaki K, Kato Y, Eguchi K, Yukawa K, Ishii N. Association between nonalcoholic fatty liver, markers of obesity, and serum leptin level in young adults. Am J Gastroenterol 2002; 97: 1796-1801
12. van Dielen FM, van,t Veer C, Buurman WA, Greve JW. Leptin and soluble leptin receptor levels in obese and weightlosing individuals. J Clin Endocrinol Metab 2002; 87: 1708-1716
13. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321
14. Couillard C. Mauriege P, Prud'homme D, Nadeau A, Tremblay A, Bouchard C, Despres JP. Plasma leptin concentrations: gender differences and associations with metabolic risk factors for cardiovascular disease. Diabetologia 1997; 40: 1178-1184
15. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763-770
16. Ankarberg-Lindgren C, Dahlgren J, Carlsson B, Rosberg S, Carlsson L, Wikland KA, Norjavaara E. Leptin levels show diurnal variation throughout puberty in healthy children, and follow a gender-specific pattern. Eur J Endocrinol 2001; 145: 43-51
17. Ahmed ML, Ong KK, Watts AP, Morrell DJ, Preece MA, Dunger DB. Elevated leptin levels are associated with excess gains in fat mass in girls, but not boys, with type 1 diabetes: longitudinal study during adolescence. J Clin Endocrinol Metab 2001; 86: 1118-1193
18. Horlick MB, Rosenbaum M, Nicolson M, Levine LS, Fedun B, Wang J, Pierson RN Jr, Leibel RL. Effect of puberty on the relationship between circulating leptin and body composition. J Clin Endocrinol Metab 2000; 85: 2509-2518
19. James OF, Day CP. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol 1998; 29: 495-501
20. Chandalia M, Garg A, Vuitch F, Nizzi F. Postmortem findings in congenital generalized lipodystrophy. J Clin Endocrinol Metab 1995; 80: 3077-3081
21. Kaplan LM. Leptin, obesity, and liver disease. Gastroenterology 1998; 115: 997-1001
22. Quinton ND, Smith RF, Clayton PE, Gill MS, Shalet S, Justice SK, Simon SA, Walters S, Postel-Vinay MC, Blakemore AI, Ross RJ. Leptin binding activity changes with age: the link between leptin and puberty. J Clin Endocrinol Metab 1999; 84: 2336-2341
23. Lewandowski K, Horn R, O'Callaghan CJ, Dunlop D, Medley GF, O'Hare P, Brabant G. Free leptin, bound leptin, and soluble leptin receptor in normal and diabetic pregnancies. J Clin Endocrinol Metab 1999; 84: 300-306
24. Voegeling S, Fantuzzi G. Regulation of free and bound leptin and soluble leptin receptors during inflammation in mice. Cytokine 2001; 14: 97-103
25. Kolaczynski JW, Considine RV, Ohannesian J, Marco C, Opentanova I, Nyce MR, Myint M, Caro JF. Responses of leptin to short-term fasting and refeeding in humans: a link with ketogenesis but not ketones themselves. Diabetes 1996; 45: 1511-1515
26. Pelleymounter MA, Cullen MJ, Healy D, Hecht R, Winters D, McCaleb M. Efficacy of exogenous recombinant murine leptin in lean and obese 10- to 12-mo-old female CD-1 mice. Am J Physiol 1998; 275: R950-R959
27. Arch JR, Stock MJ, Trayhurn P. Leptin resistance in obese humans: does it exist and what does it mean? Int J Obes Relat Metab Disord 1998; 22: 1159-1163
28. Zimmet P, Boyko EJ, Collier GR, de Courten M. Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players. Ann N Y Acad Sci 1999; 892: 25-44
29. Martin RL, Perez E, He YJ, Dawson R Jr, Millard WJ. Leptin resistance is associated with hypothalamic leptin receptor mRNA and protein downregulation. Metabolism 2000; 49: 1479-1484